Analysis and prediction of the burden of lung cancer attributable to diet low in fruits in China and the global from 1990 to 2021
Caifa Ji, Youjian Yao, Mei Gui

TL;DR
This study examines how low fruit consumption has contributed to lung cancer disease burden in China and globally from 1990 to 2021, and predicts future trends to guide prevention efforts.
Contribution
The paper provides a novel prediction of lung cancer disease burden trends due to low fruit consumption using Bayesian modeling and GBD data.
Findings
Mortality and DALY rates of lung cancer due to low fruit consumption increased in China and globally from 1990 to 2021.
Age-standardized rates of lung cancer burden due to low fruit consumption decreased significantly over the study period.
Predictions suggest a further decline in mortality and DALY rates by 2046, with male and elderly populations most affected.
Abstract
To analyze the trend of the disease burden of lung cancer attributable to diet low in fruits among the Chinese and the global populations from 1990 to 2021, describe the disease burden situation in 2021, and predict the development trend of the disease burden attributable to diet low in fruits over the next 25 years, so as to provide scientific suggestions for the prevention and control of lung cancer. The paper utilized data from the Global Burden of Disease Study 2021 (GBD 2021). The joinpoint regression model was employed to calculate the annual percentage change (APC) and the average annual percentage change (AAPC) to assess the changing trend of the burden of lung cancer attributable to diet low in fruits. The disease burden of lung cancer attributable to diet low in fruits was predicted for the next 25 years using a Bayesian age-period-cohort (BAPC) model. From 1990 to 2021, the…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment · Multiple and Secondary Primary Cancers
